Evidence map›Paper›PMID 37891529›Full record

Observational studyBMC musculoskeletal disorders2023

Net Promoter Score: a prospective, single-centre observational study assessing if a single question determined treatment success after primary or revision hip arthroplasty.

Katrin Osmanski-Zenk, Martin Ellenrieder, Wolfram Mittelmeier, Annett Klinder

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC musculoskeletal disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katrin Osmanski-ZenkOrthopaedische Klinik und Poliklinik, Medizinischen Fakultät, Universitaetsmedizin Rostock, Universität Rostock, Doberaner Strasse 142, D-18057, Rostock, Deutschland. katrin.osmanski-zenk@med.uni-rostock.de.
Martin EllenriederOrthopaedische Klinik und Poliklinik, Medizinischen Fakultät, Universitaetsmedizin Rostock, Universität Rostock, Doberaner Strasse 142, D-18057, Rostock, Deutschland.
Wolfram MittelmeierOrthopaedische Klinik und Poliklinik, Medizinischen Fakultät, Universitaetsmedizin Rostock, Universität Rostock, Doberaner Strasse 142, D-18057, Rostock, Deutschland.
Annett KlinderOrthopaedische Klinik und Poliklinik, Medizinischen Fakultät, Universitaetsmedizin Rostock, Universität Rostock, Doberaner Strasse 142, D-18057, Rostock, Deutschland.
Universitätsmedizin Rostock · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur study aimed to identify the relationship between treatment outcome assessed by patient-reported outcomes (PROMs) and satisfaction measured by calculation of the Net Promoter Score (NPS), which identifies promoters, following total hip arthroplasty (THA). The aim was to evaluate this association separately in primary and revision THA and to determine thresholds based on PROMs that identify detractors of the surgical procedure or the centre.

methodsA total of 1,243 patients who underwent primary or revision THA at our hospital were asked to complete questionnaires of the Oxford Hip Score (OHS), Euroquol-5D (EQ-5D) and information on pain intensity preoperatively, three and 12 months after surgery. Postoperatively, the patients were additionally asked about their satisfaction with the procedure and the hospital by using three different NPS questions. The association between PROMs and NPS was evaluated based on group comparisons of primary or revision THA and receiver operating characteristics analysis (ROC) to determine threshold values.

resultsAt 12 months the NPS of all three questions were invariably linked to treatment outcome in patients after primary THA and patients with a single revision. In these two treatment groups, promoters always showed significantly better PROM scores than detractors. The NPS score was always higher in the primary group in comparison to the single revision group, e.g. 66.4% would undergo the procedure again in the first group, while only 33.0% would opt for this in the latter group. The high thresholds for the PROMs at 12 months, that were calculated by ROC analysis to identify promoter/detractors, indicate that patients` satisfaction required very good joint function and pain relief. However, the NPS was not a suitable tool to identify patients who need further care in an early phase after surgery.

conclusionsWith NPS already a single question or a single parameter provides the desired information regarding patient satisfaction and also treatment success.

trial registrationThe study was approved by the Ethics Committee at the Medical Faculty of the University Rostock: "Ethikkommission an der Medizinischen Fakultät der Universität Rostock", Address: St.-Georg Str. 108 18055 Rostock, Germany, reference number: A2015-0055.

Indexed as

Arthroplasty, Replacement, HipHumansPatient Reported Outcome MeasuresPatient SatisfactionProspective StudiesSurveys and QuestionnairesTreatment OutcomeEQ-5DNPSOxford Hip scorePROMsSubscales

Identifiers

PMID37891529
PMCPMC10605956
OpenAlexW4387996287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.